# Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma

> **NCT00002221** · PHASE2 · COMPLETED · sponsor: **Ribozyome** · enrollment: 5 (—)

## Conditions studied

- Lymphoma, Non-Hodgkin
- HIV Infections

## Interventions

- **DRUG:** Peripheral blood stem cells

## Key facts

- **NCT ID:** NCT00002221
- **Lead sponsor:** Ribozyome
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 5 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002221, "Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00002221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*